QQ客服 官方微博 反馈留言

	Vildagliptin reduces lipid levels possibly by mechanisms associated with HMGCR and CYP7A1
	Du, Wenhua; Ma, Xiaoqing; Shao, Shanshan; Yu, Chunxiao; Zhao, Lifang; Fang, Li; Zhou, Lingyan; Jing, Fei
刊名	INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE
	2019
卷号	12期号:9页码:11657-11665
关键词	Dipeptidyl peptidase 4 (DPP-4) inhibitors vildagliptin lipid liver damage
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4549491
专题	山东大学
作者单位	Shandong Univ, Shandong Prov Hosp, Dept Endocrinol, 324 Wu
推荐引用方式 GB/T 7714	Du, Wenhua,Ma, Xiaoqing,Shao, Shanshan,et al. Vildagliptin reduces lipid levels possibly by mechanisms associated with HMGCR and CYP7A1[J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE,2019,12(9):11657-11665.
APA	Du, Wenhua.,Ma, Xiaoqing.,Shao, Shanshan.,Yu, Chunxiao.,Zhao, Lifang.,...&Jing, Fei.(2019).Vildagliptin reduces lipid levels possibly by mechanisms associated with HMGCR and CYP7A1.INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE,12(9),11657-11665.
MLA	Du, Wenhua,et al."Vildagliptin reduces lipid levels possibly by mechanisms associated with HMGCR and CYP7A1".INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE 12.9(2019):11657-11665.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。